Sarepta Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
CEODouglas S. Ingram
CEODouglas S. Ingram
Employees1,372
Employees1,372
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded1980
Founded1980
Employees1,372
Employees1,372
SRPT Key Statistics
Market cap2.29B
Market cap2.29B
Price-Earnings ratio-7.54
Price-Earnings ratio-7.54
Dividend yield—
Dividend yield—
Average volume2.87M
Average volume2.87M
High today$22.11
High today$22.11
Low today$21.36
Low today$21.36
Open price$21.97
Open price$21.97
Volume2.67M
Volume2.67M
52 Week high$129.84
52 Week high$129.84
52 Week low$10.42
52 Week low$10.42
Stock Snapshot
With a market cap of 2.29B, Sarepta Therapeutics(SRPT) trades at $21.70. The stock has a price-to-earnings ratio of -7.54.
During the trading session on 2025-12-30, Sarepta Therapeutics(SRPT) shares reached a daily high of $22.11 and a low of $21.36. At a current price of $21.70, the stock is +1.6% higher than the low and still -1.9% under the high.
Trading volume for Sarepta Therapeutics(SRPT) stock has reached 2.67M, versus its average volume of 2.87M.
The stock's 52-week range extends from a low of $10.42 to a high of $129.84.
The stock's 52-week range extends from a low of $10.42 to a high of $129.84.
Analyst ratings
54%
of 26 ratingsBuy
26.9%
Hold
53.8%
Sell
19.2%
People also own
Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.